TY  - JOUR

T1  - Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

JO  - Clinical Cardiology

UR  - http://eprints.whiterose.ac.uk/107084/

PY  - 2016/06/20

AU  - Gandra SR

AU  - Villa G

AU  - Fonarow GC

AU  - Lothgren M

AU  - Lindgren P

AU  - Somaratne R

AU  - van Hout B

ED  - 

DO  - DOI: 10.1002/clc.22535

VL  - 39

IS  - 6

SP  - 313

EP  - 320

Y2  - 2024/12/26

ER  -